The role of liver steatosis as measured with transient elastography and transaminases on hard clinical outcomes in patients with COVID-19

Autor: Campos Varela, Isabel, Villagrasa, Ares, Simon-Talero, Macarena, Riveiro Barciela, Mar, Ventura-Cots, Meritxell, Aguilera-Castro, Lara, Álvarez-López, Patricia, Nordahl, Emilie A., Anton, Adrian, Bañares, Juan, Barber, Claudia, Barreira-Diaz, Ana, Biagetti, Betina, Camps-Relats, Laura, Ciudin, Andreea, Cocera, Raul, Dopazo, Cristina, Fernandez, Andrea, Jiménez, Cesar, Jiménez, María M., Jofra, Mariona, Gil, Clara, Gómez Gavara, Concepción, Guanozzi, Danila, Guevara, Jorge A., Lobo, Beatriz, Malagelada Prats, Carolina, Martinez-Camprecios, Joan, Mayorga, Luis, Miret Alomar, Enric, Pando, Elizabeth, Pérez-Lopez, Ana, Pigrau Pastor, Marc, Prio, Alba, Rivera-Esteban, Jesus M., Romero, Alba, Tasayco, Staphanie, Vidal-Gonzalez, Judit, Vidal, Laura, Minguez, Beatriz, Augustin Recio, Salvador, Genescà, J., Universitat Autònoma de Barcelona

Publikováno v: Therapeutic Advances in Gastroenterology, Vol 14 (2021)
Therapeutic Advances in Gastroenterology
Scientia
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona

Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Paràmetre d'atenuació controlat; Lesió hepàtica Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Parámetro de atenuación controlado; Daño hepático Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Controlle

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2296eeef9a3d533e344ded3558d4e1ba
https://doaj.org/article/08f6ccfa64074fa7b02b6efded7b5624